OnKure Therapeutics
CO - BoulderBiotechnology
Focus: OnKure Therapeutics is a Boulder-based biotech focused on deacetylase inhibitors for cancer and rare metabolic disorders. The company operates as a pre-revenue clinical-stage biotech with a diversified pipeline spanning oncology and mitochondrial/metabolic indications.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About OnKure Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow OnKure Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxid
Fatty Acid Oxidation DisorderClinical Trials (1)
NCT04482049A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders
N/AHelp build intelligence for OnKure Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.